Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Next 10-Q

Is there any reason a 10-Q for the quarter ended 11/30/11 would not be published around mid-January?

This should provide an update on PDSG as well as the TPL Settlement and the revenues from MMP licensing, should it not?

Share
New Message
Please login to post a reply